APA (7th ed.) Citation

TG, N., & JS, K. (2025). Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities. Arthritis & rheumatology (Hoboken, N.J.), 77(12), 1626. https://doi.org/10.1002/art.43258

Chicago Style (17th ed.) Citation

TG, Newman, and Knight JS. "Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities." Arthritis & Rheumatology (Hoboken, N.J.) 77, no. 12 (2025): 1626. https://doi.org/10.1002/art.43258.

MLA (9th ed.) Citation

TG, Newman, and Knight JS. "Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities." Arthritis & Rheumatology (Hoboken, N.J.), vol. 77, no. 12, 2025, p. 1626, https://doi.org/10.1002/art.43258.